Drugs and Devices

FDA warns of counterfeit Avastin

On Feb. 14, the U.S. Food and Drug Administration notified healthcare professionals and patients about a counterfeit version of Avastin 400 mg/16mL, which may have been purchased and used by some medical practices in the United State. The counterfeit version of Avastin does not contain the medicine’s active ingredient, bevacizumab. Read more.


Related Articles:

Leave a Reply

You have to agree to the comment policy.

 

Shares